Pacitaxel in Cancer Treatment
1995

Paclitaxel in Cancer Treatment

publication

Author Information

Author(s): Maguire WP, Rowinsky EK

Conclusion

Paclitaxel is an important new agent in cancer therapy, but the optimal dose schedule is still unclear.

Supporting Evidence

  • Paclitaxel was first discovered in the bark of the western yew tree.
  • The toxic properties of yew have been known for over 2000 years.
  • Paclitaxel is the first taxane diterpenoid to find clinical utility.

Takeaway

Paclitaxel is a medicine that helps treat cancer, but doctors are still figuring out the best way to use it.

Potential Biases

Some chapters were written by employees of the Bristol Myer Squibb Company, which could introduce bias.

Limitations

The book may quickly become out of date as new studies emerge.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication